Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CD | O00329 | 16/20 | 0.59 |
| ▸ | PIK3CA | P42336 | 16/20 | 0.59 |
| ▸ | PIK3CB | P42338 | 16/20 | 0.59 |
| ▸ | PIK3CG | P48736 | 16/20 | 0.59 |
| ▸ | PRKDC | P78527 | 16/20 | 0.59 |
| ▸ | ABL1 | P00519 | 14/20 | 0.59 |
| ▸ | EGFR | P00533 | 14/20 | 0.59 |
| ▸ | HCK | P08631 | 14/20 | 0.59 |
| ▸ | SRC | P12931 | 14/20 | 0.59 |
| ▸ | MTOR | P42345 | 14/20 | 0.59 |
| ▸ | EPHB4 | P54760 | 14/20 | 0.59 |
| ▸ | KDR | P35968 | 13/20 | 0.59 |
| ▸ | PI4KB | Q9UBF8 | 6/20 | 0.59 |
| ▸ | RET | P07949 | 2/20 | 0.49 |
| ▸ | NUDT14 | O95848 | 1/20 | 0.47 |
| ▸ | NUDT5 | Q9UKK9 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL130525 | 0.84 | PIK3CD (0.55) | PIK3CDPIK3CAPIK3CBPIK3CGPRKDC | |
| SCHEMBL130500 | 0.84 | PIK3CA (0.76) | PIK3CDPIK3CAPIK3CBPIK3CGPRKDC | |
| SCHEMBL21439870 | 0.81 | PIK3CD (0.53) | PIK3CDPIK3CAPIK3CBPIK3CGPRKDC | |
| SCHEMBL31165921 | 0.81 | PIK3CD (0.53) | PIK3CDPIK3CAPIK3CBPIK3CGPRKDC | |
| SCHEMBL12282 | 0.80 | PIK3CD (0.59) | PIK3CDPIK3CAPIK3CBPIK3CGPRKDC | |
| SCHEMBL129875 | 0.77 | FGFR1 (0.55) | PIK3CDPIK3CAPIK3CBPIK3CGPRKDC | |
| SCHEMBL23917458 | 0.77 | PIK3CD (0.62) | PIK3CDPIK3CAPIK3CBPIK3CGPRKDC | |
| SCHEMBL130637 | 0.76 | PIK3CD (0.81) | PIK3CDPIK3CAPIK3CBPIK3CGPRKDC | |
| SCHEMBL23917212 | 0.75 | PIK3CD (0.79) | PIK3CDPIK3CAPIK3CBPIK3CGPRKDC | |
| SCHEMBL21436859 | 0.75 | PIK3CD (0.65) | PIK3CDPIK3CAPIK3CBPIK3CGPRKDC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090131457-A1 | Pyrazolo [3,4-D] Pyrimidine Derivatives Useful to Treat Respiratory Disorders | NOVARTIS AG (CH) | 2009-05-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090131457-A1 | Pyrazolo [3,4-D] Pyrimidine Derivatives Useful to Treat Respiratory Disorders | PIK3CA, JAK3, PDK1 | PIK3CD 7/4885PIK3CA 1/4885PIK3CB 12/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.